Brief: VBL Therapeutics Reports First Quarter 2022 Financial Results And Provides Corporate Update
17/05/2022 12:13
May 17 (Reuters) - Vascular Biogenics Ltd VBLT.O :
* VBL THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND PROVIDES
CORPORATE UPDATE
* Q1 LOSS PER SHARE $0.13
* Q1 EARNINGS PER SHARE VIEW $-0.11 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX6z5y4v
Further company coverage: VBLT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Notable Labs
See all newsUS STOCKS-Wall St ends sharply lower following Trump's anti-Powell tirade
US STOCKS-Wall St ends sharply lower amid Trump's tirade against Fed's Powell
US STOCKS-Wall St tumbles as Trump ramps up tirade against Fed's Powell
Brief: Notable Labs Says Co, Units Filed Voluntary Petition Under Provisions Of Chapter 7 Of Title 11 Of US Bankruptcy Code
Brief: Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives